274 participants
A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-31
- Start Date:
- 2025-03-14
- Completion:
- 2026-10-20
Conditions
- Neovascular Age-related Macular Degeneration (nAMD)
Interventions
- DRUG
No Results Yet